➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Mallinckrodt
Express Scripts
Dow
Merck

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Hyoscyamine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Hyoscyamine?

Hyoscyamine is an investigational drug.

There have been 3 clinical trials for Hyoscyamine. The most recent clinical trial was a Phase 1 trial, which was initiated on November 12th 2018.

The most common disease conditions in clinical trials are Abdominal Pain, Urinary Bladder Neoplasms, and Lower Urinary Tract Symptoms. The leading clinical trial sponsors are National Cancer Institute (NCI), FKD Therapies Oy of Finland, and University of Kansas Medical Center.

Recent Clinical Trials for Hyoscyamine
TitleSponsorPhase
Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent IrritationUniversity of Kansas Medical CenterPhase 4
Efficacy of Open Label Placebo in Children With FGIDsNationwide Children's HospitalN/A
Efficacy of Open Label Placebo in Children With FGIDsBoston Children’s HospitalN/A

See all Hyoscyamine clinical trials

Clinical Trial Summary for Hyoscyamine

Top disease conditions for Hyoscyamine
Top clinical trial sponsors for Hyoscyamine

See all Hyoscyamine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Mallinckrodt
Express Scripts
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.